Scarica l'app Stockscreener
35.09
1.18%
0.36
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$34.73
Aprire:
$34.8
Volume 24 ore:
155.57K
Relative Volume:
0.24
Capitalizzazione di mercato:
$1.80B
Reddito:
$276.26M
Utile/perdita netta:
$16.52M
Rapporto P/E:
114.00
EPS:
0.3078
Flusso di cassa netto:
$24.75M
1 W Prestazione:
+1.88%
1M Prestazione:
-1.40%
6M Prestazione:
-12.96%
1 anno Prestazione:
-14.13%
Intervallo 1D:
$34.44
$35.23
Intervallo di 1 settimana:
$34.15
$36.35
Portata 52W:
$28.95
$45.97
Vericel Corp Stock (VCEL) Company Profile
Nome
Vericel Corp
Settore
Industria
Telefono
(734) 930-5555
Indirizzo
64 SIDNEY ST., CAMBRIDGE, MA
Compare VCEL vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VCEL
Vericel Corp
|
35.21 | 1.77B | 276.26M | 16.52M | 24.75M | 0.3078 |
VRTX
Vertex Pharmaceuticals Inc
|
436.94 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
637.38 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.94 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
296.88 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
153.62 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Vericel Corp Stock (VCEL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-17 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-08-09 | Iniziato | Canaccord Genuity | Buy |
| 2024-06-20 | Iniziato | TD Cowen | Buy |
| 2024-01-25 | Aggiornamento | Truist | Hold → Buy |
| 2023-08-08 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-11-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-11-09 | Downgrade | Truist | Buy → Hold |
| 2022-10-14 | Ripresa | Stephens | Overweight |
| 2021-01-11 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-12-18 | Iniziato | Stephens | Overweight |
| 2020-09-17 | Iniziato | Truist | Buy |
| 2019-10-09 | Iniziato | H.C. Wainwright | Buy |
| 2019-02-28 | Downgrade | Needham | Buy → Hold |
| 2018-08-08 | Reiterato | Needham | Buy |
| 2018-07-16 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2018-04-04 | Iniziato | Leerink Partners | Outperform |
| 2018-03-06 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2018-03-06 | Reiterato | Needham | Buy |
| 2018-03-05 | Reiterato | BTIG Research | Buy |
| 2017-06-21 | Iniziato | BTIG Research | Buy |
| 2017-03-13 | Reiterato | Needham | Buy |
| 2016-12-22 | Iniziato | Piper Jaffray | Overweight |
| 2016-11-09 | Reiterato | Needham | Buy |
| 2016-04-05 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2016-03-11 | Aggiornamento | Needham | Hold → Buy |
Mostra tutto
Vericel Corp Borsa (VCEL) Ultime notizie
Q1 2026 Vericel Corp Earnings Call Transcript - GuruFocus
Q3 2025 Vericel Corp Earnings Call Transcript - GuruFocus
Vericel (VCEL) amends bylaws to reflect new Burlington, MA global headquarters - Stock Titan
Vericel Corporation $VCEL Stock Position Reduced by Truist Financial Corp - MarketBeat
Vericel (VCEL) director McLaughlin exercises options and sells 7,000 shares - Stock Titan
VCEL Stock Price, Quote & Chart | VERICEL CORP (NASDAQ:VCEL) - ChartMill
Vericel CorporationCommon Stock (NQ: VCEL - FinancialContent
Vericel director Paul Wotton sells $327,425 in company stock By Investing.com - Investing.com Australia
Insider Sell: Paul Wotton Sells 10,000 Shares of Vericel Corp (V - GuruFocus
Vericel director Paul Wotton sells $327,425 in company stock - Investing.com
Director Paul K. Wotton sells 10,000 Vericel (VCEL) shares around $33 - Stock Titan
Issuer (NASDAQ: VCEL) notifies sale of 7,000 common shares - Stock Titan
Vericel (VCEL) Eps Diluted (TTM) - Zacks Investment Research
TradingKey - TradingKey
[144] Vericel Corp SEC Filing - Stock Titan
What is HC Wainwright's Estimate for Vericel Q4 Earnings? - MarketBeat
Analysts Have Made A Financial Statement On Vericel Corporation's (NASDAQ:VCEL) First-Quarter Report - Yahoo Finance
Vericel Corporation (NASDAQ:VCEL) Q1 2026 Earnings Call Transcript - Insider Monkey
Vericel Corp (NASDAQ:VCEL): A Prime Example of Affordable Growth - ChartMill
Vericel Q1 Earnings Call Highlights - Yahoo Finance
Insider Sell: Mara Joseph Anthony Jr Sells 5,000 Shares of Veric - GuruFocus
Analysts Offer Insights on Healthcare Companies: Vericel (VCEL) and BridgeBio Pharma (BBIO) - The Globe and Mail
Vericel (VCEL) CFO 10b5-1 sale leaves 21,009 shares held - Stock Titan
Vericel (NASDAQ: VCEL) accounting chief sells 4,855 shares - Stock Titan
VCEL Maintains Buy Rating by HC Wainwright & Co. -- Price Target Raised to $64.00 - GuruFocus
Vericel Q1 2026 slides: 30% revenue growth drives guidance raise By Investing.com - Investing.com Australia
MSN Money - MSN
VCEL PE Ratio & Valuation, Is VCEL Overvalued - Intellectia AI
Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance - Ortho Spine News
Vericel Q1 2026 slides: 30% revenue growth drives guidance raise - Investing.com
Earnings call transcript: Vericel’s Q1 2026 beats forecasts, stock surges - Investing.com
Jonathan Siegal files Form 144 — VCEL (NASDAQ: VCEL) sells 3,433 shares - Stock Titan
Vericel Corporation (VCEL) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
Vericel Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Vericel Corp 1Q 2026: Revenue $68.43M, EPS ($0.12) — 10-Q Summary - TradingView
BARDA burns contract backs NexoBrid growth at Vericel (VCEL) - Stock Titan
Vericel Corp (NASDAQ:VCEL) Smashes Q1 Estimates, Raises Full-Year Outlook as MACI and Burn Care Surge - ChartMill
VERICEL ($VCEL) Releases Q1 2026 Earnings - Quiver Quantitative
Vericel Reports Q1 2026: Revenue Up 30% to $68.4M, Adjusted EBITDA $9.6M - TradingView
Vericel (NASDAQ: VCEL) lifts 2026 outlook after 30% Q1 revenue gain - Stock Titan
Vericel Corporation Reports 30% Revenue Growth to $68.4 Million in Q1 2026, Raises Full-Year Guidance to $326-$336 Million - Quiver Quantitative
Burn care sales surge 91% as Vericel lifts 2026 revenue target - Stock Titan
VCEL (NASDAQ: VCEL) Form 144 lists 3,433 shares valued $130,454; vesting noted - Stock Titan
Vericel faces earnings test as Q1 loss looms after FDA approval - Investing.com Australia
Vericel faces earnings test as Q1 loss looms after FDA approval By Investing.com - Investing.com South Africa
Global Stem Cell Therapy Market Set to Flourish at a CAGR of ~11% by 2034 Owing to the Technological Advancements and Favorable Regulations | DelveInsight - GlobeNewswire Inc.
Vericel Corp (NASDAQ:VCEL) Presents a Compelling Growth and Technical Setup Opportunity - ChartMill
Vericel Corp Azioni (VCEL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.25%
0.46%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):